CANADA – Ireland based taste and nutrition company, Kerry has signed a license agreement with Renaissance BioScience Corp to supply Renaissance’s yeast technology.

The partnership expands Kerry’s clean label offering, will see the food company commercialize Renaissance’s Acryleast, a non-GMO acrylamide-reducing yeast enzyme, to food and beverage manufacturers starting 2019.

Acryleast is a natural, non-GMO yeast enzyme that reduces acrylamide by up to 90% in a range of food and beverage products, including biscuits, crackers, French fries, potato crisps, coffee, infant food and more.

Renaissance says the clean label, effective and versatile solution has no or minimal changes to manufacturing processes and no impact on flavour, aroma and texture.

“We are delighted to announce Kerry’s partnership with Renaissance, an innovative life science company.

Their non-GMO approach to acrylamide reduction fits very well with our clean-label strategy.

We look forward to bringing this effective solution for acrylamide reduction of up to 90%, to food producers around the globe,” said Mike Woulfe, VP Business Development Enzymes, Kerry.

Renaissance also has an agreement with Orkla Food Ingredients to exclusively produce and sell Renaissance acrylamide-reducing yeast to food manufacturers in the European Nordic and Baltic markets.

The two expanded this agreement to allow Orkla commercialize Renaissance’s acrylamide-reducing yeast technology in additional new markets in Poland, the Czech Republic and Slovakia.

The licence agreement with Kerry follows new EU acrylamide regulations, which came into effect in April 2018, and California’s Proposition 65, which requires‘potentially harmful’ warning on food and beverage labels.

“Kerry is a world leader in the food and beverage industry and are an ideal partner for us to globalize Acryleast, our non-GMO acrylamide-reducing yeast enzyme.

As anticipated, there has been very high interest from food manufacturers globally for Acryleast, given changing regulations and consumer pressure.

We look forward to working with Kerry and leveraging their extensive global footprint to bring Acryleast to even more customers,” said Dr. Cormac O’Cleirigh, Chief Business Development Officer at Renaissance BioScience Corp.

Renaissance’s yeast technology portfolio includes Acrylow which has applications in baked goods and snack foods, as well as in lab-scale tests in French fries, chips and coffee.

The yeast was granted GRAS status by the U.S. FDA in 2016.